Giorgio Ballardini - Concepedia

Author

Giorgio Ballardini

Also Known As

Altmann, BOLOGNA LIVER TRANSPLANTATION GROUP (BLTG), G BALLARDINI, G Ballardini, G. BALLARDINI, G. Ballardini, Giorgio Ballardini, Giuseppina Ballardini

174

Publications

5.2K

Citations

H-Index

113

Concepts

All Affiliations

University of Bologna Medica (Italy)IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola University of Padua Ospedale Infermi di Rimini

About

Giorgio Ballardini is an author at University of Bologna specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	44	3.3K
2	Health Sciences	8	8	407
3	Public Health	1	1	36
4	Allergy	1	1	13
5	Allergy Medicine	1	1	13

Giorgio Ballardini

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial Paolo Caraceni, Oliviero Riggio, Paolo Angeli, The Lancet HepatologyDecompensated CirrhosisLiver PhysiologyGastroenterologyAcute Liver Failure	2018	499
ABERRANT EXPRESSION OF HLA-DR ANTIGENS ON BILEDUCT EPITHELIUM IN PRIMARY BILIARY CIRRHOSIS: RELEVANCE TO PATHOGENESIS Giorgio Ballardini, FrancescoB. Bianchi, Deborah Doniach, The Lancet HepatologyBiliary TractBiliary CancerLiver PhysiologyAberrant Expression	1984	498
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial Olga Vaccaro, Maria Masulli, Antonio Nicolucci, The Lancet Diabetes & Endocrinology Diabetes ManagementCardiovascular DiseaseDiabetesPharmacologyCardiovascular Pharmacology	2017	285
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity Marco Lenzi, Giorgio Ballardini, Francesco B. Bianchi, The Lancet Autoimmune DiseaseHepatitis CHepatologyViral HepatitisGeographical Heterogeneity	1991	203
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis Giorgio Ballardini, M Fallani, G. Biagini, Virchows Archiv B Cell Pathology Including Molecular Pathology	1988	152
Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis Daniela Zauli, Sabrina Ghetti, Alberto Grassi, Hepatology	1997	136
Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes Carlo Spirlı̀, Luca Fabris, Elena Duner, Gastroenterology InflammationMolecular PhysiologySignal TransductionReactive Nitrogen SpecieCell Signaling	2003	135
Characterization and Isolation of Ductular Cells Coexpressing Neural Cell Adhesion Molecule and Bcl-2 from Primary Cholangiopathies and Ductal Plate Malformations Luca Fabris, Mario Strazzabosco, Heather A. Crosby, American Journal Of Pathology Primary CholangiopathiesDevelopmental BiologyMolecular NeuroscienceEpendymaDuctal Plate Malformations	2000	125
Ito cell heterogeneity: Desmin-negative ito cells in normal rat liver Giorgio Ballardini, Paolo Groff, L. Badiali De Giorgi, Hepatology	1994	123
Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. Giorgio Ballardini, Paolo Groff, Patrizia Pontisso, Journal of Clinical Investigation Hepatitis C VirusImmunologyHepatitis BPathologyAntigen Processing	1995	121

Page 1